Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 19/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29884780 | 0.93 | ENPEP (0.62) | ENPEP | |
| SCHEMBL29599263 | 0.92 | ENPEP (0.57) | ENPEP | |
| SCHEMBL29788312 | 0.92 | ENPEP (0.63) | ENPEP | |
| SCHEMBL30876822 | 0.91 | ENPEP (0.70) | ENPEP | |
| SCHEMBL29229516 | 0.91 | ENPEP (0.56) | ENPEP | |
| SCHEMBL29229518 | 0.91 | ENPEP (0.56) | ENPEP | |
| SCHEMBL29461683 | 0.89 | ENPEP (0.67) | ENPEP | |
| SCHEMBL29788346 | 0.89 | ENPEP (0.74) | ENPEP | |
| SCHEMBL31091379 | 0.89 | ENPEP (0.56) | ENPEP | |
| SCHEMBL29598573 | 0.87 | ENPEP (0.51) | ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12630808-B2 | Modified archaeal family b polymerases | Singular Genomics Systems, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260132448-A1 | ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260125752-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12600962-B2 | High density sequencing and multiplexed priming | Singular Genomics Systems, Inc. (US) | 2026-04-14 | — | — | US | disclosed |
| EP-4720332-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | Singular Genomics Systems, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | Singular Genomics Systems, Inc. (US) | 2026-04-07 | — | — | US | disclosed |
| US-12590302-B2 | Multiplexed sequencing in cells and tissues | Singular Genomics Systems, Inc. (US) | 2026-03-31 | — | — | US | disclosed |
| US-11359238-B2 | Linked paired strand sequencing | Singular Genomics Systems, Inc. | 2022-06-14 | — | — | US | disclosed |
| US-20220170092-A1 | METHODS FOR LONG READ SEQUENCING | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-06-02 | — | — | US | disclosed |
| US-20220136048-A1 | METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-05-05 | — | — | US | disclosed |
| WO-2022094415-A1 | METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES | Singular Genomics Systems, Inc. (US) | 2022-05-05 | — | — | WO | disclosed |
| US-20220127299-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | LG ELECTRONICS INC. (KR) | 2022-04-28 | — | — | US | disclosed |
| WO-2022087485-A1 | NUCLEIC ACID CIRCULARIZATION AND AMPLIFICATION ON A SURFACE | Singular Genomics Systems, Inc. (US) | 2022-04-28 | — | — | WO | disclosed |
| US-20220119780-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-04-21 | — | — | US | disclosed |
| US-20220119878-A1 | LINKED PAIRED STRAND SEQUENCING | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-04-21 | — | — | US | disclosed |
| US-20220119779-A1 | MODIFIED PYROCOCCUS POLYMERASES AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2022-04-21 | — | — | US | disclosed |
| US-11266673-B2 | Nucleotide derivatives and methods of use thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630808-B2 | Modified archaeal family b polymerases | SSU72, POLB, POLQ | ENPEP 464/4885 |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | NSUN2, CCRL2, NOP2 | ENPEP 4478/4885 |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | NSUN2, POLR2H, POLH | ENPEP 3733/4885 |
| US-12600962-B2 | High density sequencing and multiplexed priming | DNMT3A, POLM, POLN | ENPEP 4368/4885 |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | POLL, POLB, POLN | ENPEP 1220/4885 |
| US-20220127299-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | NUDT21, CPSF7, DCLRE1A | ENPEP 365/4885 |
| US-20260125752-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | DNMT3L, DNMT3A, FBL | ENPEP 2570/4885 |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | DNMT3A, POLB, POLM | ENPEP 133/4885 |
| US-20260132448-A1 | ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS | FLNA, FLNB, PHAX | ENPEP 3455/4885 |
| US-12590302-B2 | Multiplexed sequencing in cells and tissues | TPM4, DNMT3A, PROX1 | ENPEP 2178/4885 |
| US-11266673-B2 | Nucleotide derivatives and methods of use thereof | POLRMT, NSUN2, NUDT1 | ENPEP 1387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.